AI Engines For more Details: Perplexity Kagi Labs You
Multiple Sclerosis (MS): Ibudilast has shown promise in the treatment of multiple sclerosis, a chronic autoimmune disorder affecting the central nervous system. It may help reduce inflammation and slow down the progression of the disease.
Asthma: Ibudilast has bronchodilator properties, meaning it helps to widen the airways in the lungs. This can be beneficial in the treatment of asthma, a condition characterized by airway inflammation and constriction.
Chronic Obstructive Pulmonary Disease (COPD): Similar to its effects in asthma, ibudilast's bronchodilator properties may help alleviate symptoms in COPD, a group of progressive lung diseases including chronic bronchitis and emphysema.
Neuroinflammation: Ibudilast has been investigated for its potential to reduce neuroinflammation, which is implicated in various neurological disorders such as Alzheimer's disease, Parkinson's disease, and neuropathic pain.
Depression and Anxiety: Some research suggests that ibudilast may have antidepressant and anxiolytic (anti-anxiety) effects, possibly due to its anti-inflammatory actions in the brain.
Substance Use Disorders: Ibudilast has been studied for its potential to reduce cravings and withdrawal symptoms associated with substance use disorders, particularly in alcohol and opioid dependence.
Chronic Pain: Ibudilast's anti-inflammatory and neuroprotective properties may offer relief from chronic pain conditions such as neuropathic pain and fibromyalgia.
Stroke Recovery: There is some evidence to suggest that ibudilast may aid in stroke recovery by reducing inflammation and promoting neural repair and regeneration.
Glaucoma: In ophthalmology, ibudilast has been explored for its potential to lower intraocular pressure and protect retinal ganglion cells, making it a possible treatment option for glaucoma.
Retinal Disorders: Ibudilast's neuroprotective effects extend to the retina, where it may help preserve retinal function and prevent vision loss in conditions such as diabetic retinopathy and retinal degenerative diseases.
Rank | Probiotic | Impact |
---|---|---|
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Blautia hansenii | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Blautia obeum | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Bacteroides humanifaecis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Bacteroides sp. CACC 737 | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Bacteroides sp. HF-162 | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Blautia hansenii | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Bacteroides sp. A1C1 | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Blautia producta | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | [Clostridium] scindens | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Rothia dentocariosa | species | Decreases |
0 | 1 | Enterocloster bolteae | species | Decreases |
0 | 1 | Anaerostipes caccae | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Streptococcus canis | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.4 | 0.4 | |
ADHD | 1.2 | 0.7 | 0.71 |
Age-Related Macular Degeneration and Glaucoma | 0.4 | 0.2 | 1 |
Allergic Rhinitis (Hay Fever) | 1.6 | 0.8 | 1 |
Allergies | 2.5 | 0.3 | 7.33 |
Allergy to milk products | 1.2 | 0.9 | 0.33 |
Alopecia (Hair Loss) | 0.3 | 0.1 | 2 |
Alzheimer's disease | 2.6 | 3 | -0.15 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.4 | 0.7 | 1 |
Ankylosing spondylitis | 1.5 | 0.8 | 0.88 |
Anorexia Nervosa | 0.4 | 1.2 | -2 |
Antiphospholipid syndrome (APS) | 1.3 | 1.3 | |
Asthma | 1.6 | 0.4 | 3 |
Atherosclerosis | 1.5 | 0.9 | 0.67 |
Atrial fibrillation | 1.3 | 1.1 | 0.18 |
Autism | 4 | 3.7 | 0.08 |
Autoimmune Disease | 0.5 | 0.3 | 0.67 |
Barrett esophagus cancer | 0 | 0 | |
benign prostatic hyperplasia | 0.5 | 0.2 | 1.5 |
Biofilm | 1.2 | 1.2 | |
Bipolar Disorder | 1 | 0.5 | 1 |
Brain Trauma | 0.1 | 0.4 | -3 |
Breast Cancer | 0.6 | 0.6 | |
Cancer (General) | 0.1 | 0.6 | -5 |
Carcinoma | 0.8 | 0.5 | 0.6 |
Celiac Disease | 2 | 0.5 | 3 |
Cerebral Palsy | 0.3 | 0.4 | -0.33 |
Chronic Fatigue Syndrome | 2.7 | 4 | -0.48 |
Chronic Kidney Disease | 1.9 | 1.3 | 0.46 |
Chronic Lyme | 0.4 | -0.4 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0.9 | 0.5 | 0.8 |
Chronic Urticaria (Hives) | 1 | 0.5 | 1 |
Coagulation / Micro clot triggering bacteria | 1.3 | 0.2 | 5.5 |
Cognitive Function | 0.4 | 0.4 | 0 |
Colorectal Cancer | 3.6 | 1.5 | 1.4 |
Constipation | 1 | 0.2 | 4 |
Coronary artery disease | 1.9 | 1.8 | 0.06 |
COVID-19 | 4.6 | 5.5 | -0.2 |
Crohn's Disease | 4.8 | 1.9 | 1.53 |
Cushing's Syndrome (hypercortisolism) | 0.5 | -0.5 | |
cystic fibrosis | 0.8 | 0.4 | 1 |
d-lactic acidosis (one form of brain fog) | 0.6 | 0.6 | |
deep vein thrombosis | 1.8 | 0.4 | 3.5 |
Denture Wearers Oral Shifts | 0.2 | 0.2 | |
Depression | 4.7 | 4 | 0.18 |
Dermatomyositis | 0 | 0 | |
Eczema | 1.2 | 0.6 | 1 |
Endometriosis | 1.8 | 1.2 | 0.5 |
Eosinophilic Esophagitis | 0 | 0 | |
Epilepsy | 2.1 | 1 | 1.1 |
erectile dysfunction | 0.8 | 0.8 | |
Fibromyalgia | 1.5 | 1.5 | 0 |
Functional constipation / chronic idiopathic constipation | 3.3 | 1.7 | 0.94 |
gallstone disease (gsd) | 2.4 | 0.2 | 11 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.8 | 0.7 | 0.14 |
Generalized anxiety disorder | 2.1 | 0.7 | 2 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0 | 0 | |
Gout | 0.2 | 0.6 | -2 |
Graves' disease | 0.4 | 0.5 | -0.25 |
Gulf War Syndrome | 0.5 | 0.8 | -0.6 |
Halitosis | 0.2 | 0.1 | 1 |
Hashimoto's thyroiditis | 1.2 | 0.4 | 2 |
Heart Failure | 2.5 | 0.6 | 3.17 |
hemorrhagic stroke | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 0.2 | 0.2 | |
High Histamine/low DAO | 1.1 | 1.1 | |
hypercholesterolemia (High Cholesterol) | 0.8 | 0.2 | 3 |
hyperglycemia | 1 | 0.4 | 1.5 |
hypertension (High Blood Pressure | 1.7 | 1.8 | -0.06 |
Hypothyroidism | 0.3 | -0.3 | |
Hypoxia | 0.8 | 0.8 | |
IgA nephropathy (IgAN) | 0.4 | 2 | -4 |
Inflammatory Bowel Disease | 4.3 | 3.9 | 0.1 |
Insomnia | 0.7 | 0.5 | 0.4 |
Intelligence | 1.7 | 0 | 0 |
Intracranial aneurysms | 0.4 | 0.3 | 0.33 |
Irritable Bowel Syndrome | 2.5 | 2 | 0.25 |
ischemic stroke | 1 | 0.9 | 0.11 |
Liver Cirrhosis | 2.7 | 1.4 | 0.93 |
Long COVID | 3.6 | 2.1 | 0.71 |
Low bone mineral density | 0.8 | -0.8 | |
Lung Cancer | 0.5 | 0.2 | 1.5 |
Lymphoma | 0.5 | 0.5 | |
Mast Cell Issues / mastitis | 0.5 | 0.3 | 0.67 |
ME/CFS with IBS | 0.4 | 2 | -4 |
ME/CFS without IBS | 1.1 | 1 | 0.1 |
membranous nephropathy | 0 | 0 | |
Menopause | 0.4 | 0.3 | 0.33 |
Metabolic Syndrome | 3.5 | 3 | 0.17 |
Mood Disorders | 4.1 | 3.3 | 0.24 |
multiple chemical sensitivity [MCS] | 0 | 0 | |
Multiple Sclerosis | 1.7 | 2.8 | -0.65 |
Multiple system atrophy (MSA) | 0.2 | 0.2 | |
myasthenia gravis | 0.5 | 0.3 | 0.67 |
neuropathic pain | 0.9 | -0.9 | |
Neuropathy (all types) | 0 | 0.9 | 0 |
neuropsychiatric disorders (PANDAS, PANS) | 0.7 | 0.7 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.2 | 1.4 | 0.57 |
NonCeliac Gluten Sensitivity | 0.2 | 0.2 | 0 |
Obesity | 4 | 3.2 | 0.25 |
obsessive-compulsive disorder | 3.4 | 1.5 | 1.27 |
Osteoarthritis | 2.1 | 0.4 | 4.25 |
Osteoporosis | 0.9 | 0.2 | 3.5 |
pancreatic cancer | 0.1 | 0 | 0 |
Parkinson's Disease | 3.6 | 3.1 | 0.16 |
Polycystic ovary syndrome | 4.1 | 0.6 | 5.83 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.3 | -2 |
Premenstrual dysphoric disorder | 0.2 | -0.2 | |
primary biliary cholangitis | 0 | 0.6 | 0 |
Primary sclerosing cholangitis | 0.8 | 2.2 | -1.75 |
Psoriasis | 1.4 | 1.4 | 0 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.5 | 1.6 | 0.56 |
Rosacea | 0.2 | 0.3 | -0.5 |
Schizophrenia | 2.1 | 1.1 | 0.91 |
scoliosis | 1.1 | 1.1 | |
sensorineural hearing loss | 0.4 | 0.4 | |
Sjögren syndrome | 0.8 | 1 | -0.25 |
Sleep Apnea | 0.6 | 0.7 | -0.17 |
Slow gastric motility / Gastroparesis | 0.7 | 0.7 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.4 | 1.4 | |
Stress / posttraumatic stress disorder | 1.4 | 0.9 | 0.56 |
Systemic Lupus Erythematosus | 2.5 | 0.5 | 4 |
Tic Disorder | 0.5 | 0.4 | 0.25 |
Tourette syndrome | 0 | 0.2 | 0 |
Type 1 Diabetes | 2.2 | 1.1 | 1 |
Type 2 Diabetes | 4.3 | 3.4 | 0.26 |
Ulcerative colitis | 3.1 | 3.6 | -0.16 |
Unhealthy Ageing | 2.2 | 1 | 1.2 |
Vitiligo | 0.9 | 1 | -0.11 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]